| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.026 | 0.9 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.02 | 0.9 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |